Fed. Circ. OKs ITC Ruling That Bio-Rad Infringed 10x Patents
10x Genomics scored a victory in its patent battle with Bio-Rad when the Federal Circuit on Thursday upheld the U.S. International Trade Commission's finding that Bio-Rad infringed three patents covering microfluidic...To view the full article, register now.
Already a subscriber? Click here to view full article